SBIO (ALPS Medical Breakthroughs ETF) Stock Analysis

ALPS Medical Breakthroughs ETF (SBIO) is a publicly traded the market company. As of May 20, 2026, SBIO trades at $58.43 with a market cap of $0 and a P/E ratio of 0.00. SBIO moved +0.00% today. Year to date, SBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest SBIO stock research?

ALPS Medical Breakthroughs ETF (SBIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SBIO moved +0.00% today.

SBIO Key Metrics

Key financial metrics for SBIO
MetricValue
Price$58.43
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume114.58K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

SBIO Analyst Consensus

SBIO analyst coverage data. Average price target: $0.00.

Common questions about SBIO

What can I research for SBIO on Rallies?
ALPS Medical Breakthroughs ETF (SBIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SBIO moved +0.00% today.
Does Rallies show live market data for SBIO?
Rallies combines live market context with ticker research for SBIO, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
SBIO

SBIO